A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD
Status:
Completed
Trial end date:
2014-11-04
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the effect of fluticasone furoate/vilanterol
Inhalation Powder on arterial stiffness compared with placebo and vilanterol over a 24-week
treatment period in subjects with COPD and aortic pulse wave velocity of 11.0 m/s or above.